Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Save to My Library
Look up keyword
Like this
4Activity
0 of .
Results for:
No results containing your search query
P. 1
IFPMA Code of Practice 2012

IFPMA Code of Practice 2012

Ratings: (0)|Views: 1,596 |Likes:
Published by corruptioncurrents

More info:

Published by: corruptioncurrents on Mar 01, 2012
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

03/01/2012

pdf

text

original

 
International Federationof PharmaceuticalManufacturers & Associations
IFPMACode of Practice
 2012
 
Foreword 
Advancing medical knowledge and improving global public health depend oninormation-sharing interactions by the entire medical community - rom researcherto attending physician and nurse to patient – and integrity is essential to theseexchanges. Fundamentally, there must always be confdence that prescriptiondecisions are made on an ethical and patient-ocused basis.In these interactions, it is essential that governments, the healthcare communityand patients are confdent that pharmaceutical companies, wherever they operatein the world, act in an ethical and proessional manner. Such ethical practices shouldapply not only to the promotion o medicines but more broadly to all interactionswith the healthcare community. This is the commitment that we, the InternationalFederation o Pharmaceutical Manuacturers and Associations (IFPMA) representingthe research-based pharmaceutical industry, make in our recently-revisedCode o Practice.Since its initial adoption in 1981 as the oundation o a global sel-regulatoryapproach, the Code has been regularly updated and strengthened to adaptto changing needs. The scope o the 2012 revision extends this already highstandard o pharmaceutical industry practice beyond marketing practices to coverall interactions with healthcare proessionals, medical institutions and patientorganizations.Success o the Code requires high awareness levels o both the standard itsel as wellas the established procedures or registering complaints. IFPMA member companiesare committed to inorming all their 1.3 million employees about the Code as wellas to providing thorough training. While our industry holds itsel accountable toconduct business with the highest possible ethics, we encourage others – doctors,pharmacists, nurses, academicians, patients and consumers – to become aware o this new benchmark and to ensure equally high ethical practice throughout thehealthcare sector.Focused on serving the best interests o patients, we have a moral obligationto communicate and participate in all relationships with integrity, accuracy andclarity. The IFPMA Code o Practice is a tangible example o the research-basedpharmaceutical industry’s commitment to making a strong contribution to globalpublic health while adhering to the highest standard o practice.
Eduardo Pisani
Director GeneralInternational Federation o PharmaceuticalManuacturers and Associations (IFPMA)
 
Table of Contents
Page2
IFPMA Guiding Principles on Ethical Conductand Promotion 
3
Preamble 
4
Scope and Denitions
(Article 1)
 Basis of Interactions
(Article 2)
2.1 Basis o Interactions2.2 Transparency o Promotion 5
Pre-Approval Communications andO-Label Use
(Article 3)
 Standards of Promotional Information
(Article 4)
4.1 Consistency o Product Inormation4.2 Accurate and Not Misleading4.3 Substantiation 6
Printed Promotional Material
(Article 5)
5.1 All Printed Promotional Materialincluding Advertisements5.2 Reminder Advertisements 
Electronic Materials, including Audiovisuals
(Article 6)
7
Interactions with Healthcare Professionals
(Article 7)
7.1 Events and Meetings7.1.1 Scientifc and Educational Objectives7.1.2 Events Involving Foreign Travel7.1.3 Promotional Inormation at Events7.1.4 Appropriate Venue7.1.5 Limits7.1.6 Entertainment7.2 Sponsorships7.3 Guests7.4 Fees or Services7.5 Gits and Other Items7.5.1 Prohibition o Cash and Personal Gits7.5.2 Promotional Aids7.5.3 Items o Medical Utility7.5.4 Guidance on ValuesPage10
Samples
(Article 8)
 
8.1 Samples8.2 Control and Accountability 
Clinical Research and Transparency
(Article 9)
9.1 Transparency9.2 Distinction rom Promotion 
Support for Continuing Medical Education
(Article 10)
11
Interactions with Patient Organizations
(Article 11)
11.1 Scope11.2 Declaration o Involvement11.3 Written Documentation11.4 Events 
Company Procedures and Responsibilities
(Article 12)
12.1 Procedures12.2 Training12.3 Responsibilities or ApprovingPromotional Communications12
Infringements, Complaints andEnforcement
(Article 13)
13.1 Complaints13.2 Measures to Ensure and EnorceCompliance13
IFPMA
 
Code of Practice Operating Procedure
(Appendix 1)
16
IFPMA Secretariat Standard OperatingProcedures
(Appendix 2)
18
Questions & Answers
 
IFPMA Code oPractice1

Activity (4)

You've already reviewed this. Edit your review.
1 thousand reads
1 hundred reads

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->